Melanoma incidence in Norway, 1980–2024: a cohort study

Background Norway has one of the world's highest melanoma incidence rates. Despite preventive efforts, their long-term impact remains unclear. We examined sex- and age-specific melanoma trends in Norway. Methods We used nationwide Cancer Registry data on first primary melanoma in Norway during 1980–2024. Incidence rates were age-standardised to the European Standard Population 2013. Joinpoint regression estimated average annual percentage changes (AAPCs) with 95% confidence intervals (CIs), by sex, age, region, anatomical site, and subtype. Age-period-cohort analyses assessed temporal patterns. Findings Among 60,722 individuals with melanoma, 29,775 (49.0%) were male. Overall, incidence increased by 2·4–2·7% yearly in 1980–2024 in both sexes. Trends diverged, with stable or declining incidence among younger individuals and continued increases exceeding 5% [5·2, 6·6] in the oldest groups. Birth-cohort analyses identified a strong birth-cohort effect, with progressively increasing incidence across successive older birth cohorts, whereas younger cohorts showed stable or declining incidence. Northern Norway had the largest regional increases (AAPC 4·6 [3·8, 5·3] in males and 3·1 [2·5, 3·8] in females). Incidence increased particularly on the head and neck in men and the trunk and upper limbs in women. Superficial spreading melanoma showed the strongest increase among subtypes (4·1 [3·7, 4·6] and 3·1 [2·8, 3·5], respectively). Interpretation Melanoma incidence in Norway continues to rise mainly among older adults, while trends in younger generations are stabilising or declining. Cohort patterns and regional differences are consistent with potential changes in UVR-related behaviours. These findings support the need for targeted prevention strategies for groups with persistently increasing incidence. Funding None.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2026-09-30
DOI
https://doi.org/10.1016/j.lanepe.2026.101882
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Melanoma incidence in Norway, 1980–2024: a cohort study

Reza Ghiasvand, Trude Eid Robsahm, Saha Samimi
The Lancet Regional Health - Europe
Cutaneous Melanoma Detection and Management
article

Melanoma incidence in Norway, 1980–2024: a cohort study

Reza Ghiasvand, Trude Eid Robsahm, Saha Samimi
article en

Abstract

Background Norway has one of the world's highest melanoma incidence rates. Despite preventive efforts, their long-term impact remains unclear. We examined sex- and age-specific melanoma trends in Norway. Methods We used nationwide Cancer Registry data on first primary melanoma in Norway during 1980–2024. Incidence rates were age-standardised to the European Standard Population 2013. Joinpoint regression estimated average annual percentage changes (AAPCs) with 95% confidence intervals (CIs), by sex, age, region, anatomical site, and subtype. Age-period-cohort analyses assessed temporal patterns. Findings Among 60,722 individuals with melanoma, 29,775 (49.0%) were male. Overall, incidence increased by 2·4–2·7% yearly in 1980–2024 in both sexes. Trends diverged, with stable or declining incidence among younger individuals and continued increases exceeding 5% [5·2, 6·6] in the oldest groups. Birth-cohort analyses identified a strong birth-cohort effect, with progressively increasing incidence across successive older birth cohorts, whereas younger cohorts showed stable or declining incidence. Northern Norway had the largest regional increases (AAPC 4·6 [3·8, 5·3] in males and 3·1 [2·5, 3·8] in females). Incidence increased particularly on the head and neck in men and the trunk and upper limbs in women. Superficial spreading melanoma showed the strongest increase among subtypes (4·1 [3·7, 4·6] and 3·1 [2·8, 3·5], respectively). Interpretation Melanoma incidence in Norway continues to rise mainly among older adults, while trends in younger generations are stabilising or declining. Cohort patterns and regional differences are consistent with potential changes in UVR-related behaviours. These findings support the need for targeted prevention strategies for groups with persistently increasing incidence. Funding None.

The Lancet Regional Health - EuropeVol. 71
Oslo University Hospital (NO), Norwegian Institute of Public Health (NO), Zimmer Biomet (Netherlands) (NL), Cancer Registry of Norway (NO), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 15%
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.